Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels (Q42243817)

19 October 2017

title

Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels (English)

1 reference

19 October 2017

1 reference

12

Jean-Pierre Zarski

0 references

author name string

Evelyne Jouvin-Marche

1

1 reference

19 October 2017

Zuzana Macek Jílková

2

1 reference

19 October 2017

Marie-Ange Thelu

3

1 reference

19 October 2017

Helene Marche

4

1 reference

19 October 2017

Emilie Fugier

5

1 reference

19 October 2017

Nicolas Van Campenhout

6

1 reference

19 October 2017

Xuan Su Hoang

7

1 reference

19 October 2017

Alice Marlu

8

1 reference

19 October 2017

Nathalie Sturm

9

1 reference

19 October 2017

Mary Callanan

10

1 reference

19 October 2017

Vincent Leroy

11

1 reference

19 October 2017

Jean-Pierre Zarski

12

1 reference

19 October 2017

Patrice N Marche

13

1 reference

19 October 2017

language of work or name

English

0 references

publication date

9 January 2014

1 reference

Journal of Infectious Diseases

19 October 2017

published in

1 reference

19 October 2017

volume

209

1 reference

19 October 2017

issue

12

1 reference

19 October 2017

page(s)

1907-1915

1 reference

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

A view to natural killer cells in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

The role of natural killer cells in hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

The natural killer cell response to HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Interferon signaling and treatment outcome in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

T cell responses in hepatitis C: the good, the bad and the unconventional

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Natural killer cells in viral hepatitis: facts and controversies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Introduction to the genetics and biology of interleukin-28B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Genetic variation in the interleukin -28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU016

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIU016

1 reference

19 October 2017

1 reference